Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.725 USD | -0.86% | -2.81% | -48.05% |
Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Jun. 05 | Coherus BioSciences, Inc. Appoints Rita Karachun to Its Board of Directors | CI |
Financials (USD)
Sales 2024 * | 261M | Sales 2025 * | 358M | Capitalization | 200M |
---|---|---|---|---|---|
Net income 2024 * | 60M | Net income 2025 * | -14M | EV / Sales 2024 * | 1.79 x |
Net Debt 2024 * | 268M | Net Debt 2025 * | 286M | EV / Sales 2025 * | 1.36 x |
P/E ratio 2024 * |
5.39
x | P/E ratio 2025 * |
-7.65
x | Employees | 249 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.96% |
Latest transcript on Coherus BioSciences, Inc.
1 day | +2.96% | ||
1 week | -1.14% | ||
Current month | -4.40% | ||
1 month | -8.42% | ||
3 months | -27.20% | ||
6 months | -21.62% | ||
Current year | -47.75% |
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-11 | 1.73 | -0.57% | 751 254 |
24-06-10 | 1.74 | +2.96% | 1,298,360 |
24-06-07 | 1.69 | -2.87% | 905,027 |
24-06-06 | 1.74 | -3.87% | 1,029,349 |
24-06-05 | 1.81 | +1.69% | 884,856 |
Delayed Quote Nasdaq, June 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.75% | 200M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+3.00% | 22.39B | |
-11.39% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- CHRS Stock